spacer
home > pmps > winter 2017 > working together
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Working Together

If the pharmaceutical supply chain was a living, breathing creature, it would probably be the microscopic water flea. Daphnia pulex was the first crustacean to have its genome sequenced, and results showed that it has 31,000 genes 25% more than us humans. Just like the genetic complexity of the water flea was a challenge for scientists, the sophisticated pharma supply chain is now changing the way the industry operates.

The rise of emerging markets and the different geographic standards used around the world are additional challenges that manufacturers need to address. As always in the pharma sector, the complex regulatory landscape has a significant impact on companies. This includes widely recognised guidelines such as those from the FDA and their European counterparts, as well as client standards and environmental legislation. All of these factors are contributing to making the supply chain nearly impossible to navigate.

Current Situation

As new markets and technologies emerge in the pharma field, manufacturers are starting to feel the pressure of working with a higher number of suppliers, partners and distributors. They often produce drugs for pharmacies or specific patients, rather than wholesale this means that the industry is starting to be driven by demand rather than forecast. The medicines themselves are becoming progressively complex and bespoke, meaning that the production of mini batches or personalised medicine is another rising trend.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Darren Halford is Sales Director at obsolete components supplier EU Automation. Previously, he has worked as a recruitment consultant, recommending new employment opportunities to senior construction professionals. Darren oversees all sales and service operations and has been with the company since its inception in May 2009.
spacer
Darren Halford
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >>

White Papers
 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement